CrushSCI.com
Journal Selection & Manuscript Polishing Services
BREAST CANCER RESEARCH AND TREATMENT journal cover Medicine
Back to journal directory

Review Cycle Records

BREAST CANCER RESEARCH AND TREATMENT

Springer SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
119.1Average days
115.5Median days
27Fastest days
191Longest days
2962025 publications

Paper Review Records

All Paper Review Records

14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

78 days

Breast skin ulceration in de novo metastatic breast cancer: incidence, predictors, and patterns of occurrence

AuthorsCelian Guyon; Fabien Guffroy; Jonathan Sabah; Louna Mossino Diaz; Luc Cabel; Jean-Yves Pierga; Toulsie Ramtohul; Pierre Loap; Claire Bonneau; Helene Didelot; Enora Laas; Thomas Gaillard

Affiliations1. Department of Surgical Oncology, Institut Curie, Paris, France; 2. Institut Curie, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Paris, France; 3. Department of Medical Oncology, Institut Curie, Paris, France; 4. Université Paris Cité, Paris, France; 5. Department of Radiology, Institut Curie, Paris, France; 6. Department of Radiation Therapy, Institut Curie, Paris, France; 7. Department of Surgical Oncology, Institut Curie, Saint Cloud, France; 8. Université Versailles Saint-Quentin, Versailles, France

Source PDF DOI Publisher page
185 days

Self-reported racial and ethnic discrimination in patient-provider interactions and the initiation of adjuvant therapies for breast cancer in the pathways study

AuthorsKevin R. Bitsie; Thomas A. Pearson; Marilyn L. Kwan; Lusine Yaghjyan; Lisa Scarton; Salma Shariff-Marco; Therese Y. Andraos; Lia L. D’Addario; Lawrence H. Kushi; Ting-Yuan David Cheng

Affiliations1. Dalla Lana School of Public Health, University of Toronto, Toronto, Canada; 2. Department of Epidemiology, University of Florida, Gainesville, USA; 3. Division of Research, Kaiser Permanente Northern California, Pleasanton, USA; 4. College of Nursing, University of Florida, Gainesville, USA; 5. Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, San Francisco, USA; 6. Comprehensive Cancer Center, The Ohio State University, Columbus, USA; 7. Division of Cancer Prevention and Control, Department of Internal Medicine, The Ohio State University, Columbus, USA

Source PDF DOI Publisher page
112 days

Locoregional recurrence and mortality after breast cancer surgery in patients aged 85 and older

AuthorsDavid Foulad; Jacqueline Tsai; Ingrid Luo; Adele Xu; Mina Satoyoshi; Su-Ying Liang; Pragati Kenkare; Summer Han; Allison W. Kurian; Irene L. Wapnir

Affiliations1. Department of Surgery, Stanford University School of Medicine, Stanford, USA; 2. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, USA; 3. Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, USA; 4. Department of Medicine, Stanford University School of Medicine, Stanford, USA; 5. Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, USA; 6. Palo Alto Medical Foundation Research Institute and Sutter Health’s Center for Health Systems Research, Palo Alto, USA

Source PDF DOI Publisher page
142 days

First-line treatment patterns and real-world survival outcomes in PD-L1-negative locally recurrent inoperable or metastatic triple-negative breast cancer in the United States

AuthorsTiffany A. Traina; Elizabeth Serra; Jerome Bedard; Mohira Levesque-Leroux; Patrick Gagnon-Sanschagrin; Annie Guérin; Silke Guenther; George Joseph; Victoria Guan; Jonathan Salcedo

Affiliations1. Department of Medicine, Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, USA; 2. Weill Cornell Medicine, New York City, USA; 3. Analysis Group ULC, Montréal, Canada; 4. BioNTech SE, Mainz, Germany; 5. BioNTech US, Inc., Cambridge, USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.